Why the study?
Ensuring a more equal allocation of healthcare funds for patients facing high costs of care motivated this study to estimate optimal co-insurance for outpatient drug costs.
Cross-Sectional (n=193,552)
Implementing an optimal co-insurance strategy based on risk stratification can improve access to costly medications for vulnerable populations and help insurers distribute funds more efficiently.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Soni et al. (2026) conducted a cross-sectional in Outpatient prescription claims (n=193,552). Optimal co-insurance estimation was evaluated on Optimal co-insurance estimates and insurer's expenses alteration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: